Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1997-10

AUTHORS

T Parkkali, M Stenvik, T Ruutu, T Hovi, L Volin, P Ruutu

ABSTRACT

Forty-five adult HLA-matched sibling BMT recipients were randomized to receive inactivated poliovirus vaccine (IPV) at 6, 8 and 14 months (early group, n = 23) or at 18, 20 and 26 months after BMT (late group, n = 22). Ninety-five percent of the early group patients had protective antibody titres of > or = 4 to poliovirus type 1 (PV1), poliovirus type 2 (PV2) and poliovirus type 3 (PV3) by a microneutralization assay prior to the first vaccination, at 6 months after BMT. The corresponding proportion for the late group patients was only 67% at 18 months. The antibody responses 1 month after each of the three IPV doses were similar in the two vaccination groups, except that four-fold responses occurred more frequently after the first dose to PV2 and PV3 in the late group. All patients had a protective antibody titre to all poliovirus serotypes 1 and 22 months after the third vaccine dose, except one patient in the early group who lacked antibodies to PV3 at 22 months. Acute GVHD accelerated the decrease of poliovirus antibody titres prior to vaccination but had no influence on vaccination response. Chronic GVHD neither influenced the patient's ability to retain poliovirus antibodies prior to vaccination nor impaired responses to vaccinations. A vaccination schedule consisting of three IPV doses was equally immunogenic when started at 6 or 18 months after allogeneic BMT. More... »

PAGES

663

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1700959

DOI

http://dx.doi.org/10.1038/sj.bmt.1700959

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023503902

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9383230


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Poliomyelitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Poliovirus Vaccine, Inactivated", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaccines, Inactivated", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Department of Medicine, Helsinki University Central Hospital, Finland."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parkkali", 
        "givenName": "T", 
        "id": "sg:person.0676322133.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676322133.64"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Stenvik", 
        "givenName": "M", 
        "id": "sg:person.01314120305.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314120305.26"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ruutu", 
        "givenName": "T", 
        "id": "sg:person.01370647451.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370647451.25"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Hovi", 
        "givenName": "T", 
        "id": "sg:person.0630657606.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630657606.65"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Volin", 
        "givenName": "L", 
        "id": "sg:person.07531174677.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531174677.79"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ruutu", 
        "givenName": "P", 
        "id": "sg:person.0741022770.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741022770.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199501193320303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006006309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1699-0463.1996.tb00731.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042871098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1699-0463.1996.tb00731.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042871098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(80)90380-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048876793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197504242921706", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052170577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/clinids/18.4.547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059472952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/clinids/6.supplement_2.s540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059475455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/159.4.610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059701378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/162.2.496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059702155"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-10", 
    "datePublishedReg": "1997-10-01", 
    "description": "Forty-five adult HLA-matched sibling BMT recipients were randomized to receive inactivated poliovirus vaccine (IPV) at 6, 8 and 14 months (early group, n = 23) or at 18, 20 and 26 months after BMT (late group, n = 22). Ninety-five percent of the early group patients had protective antibody titres of > or = 4 to poliovirus type 1 (PV1), poliovirus type 2 (PV2) and poliovirus type 3 (PV3) by a microneutralization assay prior to the first vaccination, at 6 months after BMT. The corresponding proportion for the late group patients was only 67% at 18 months. The antibody responses 1 month after each of the three IPV doses were similar in the two vaccination groups, except that four-fold responses occurred more frequently after the first dose to PV2 and PV3 in the late group. All patients had a protective antibody titre to all poliovirus serotypes 1 and 22 months after the third vaccine dose, except one patient in the early group who lacked antibodies to PV3 at 22 months. Acute GVHD accelerated the decrease of poliovirus antibody titres prior to vaccination but had no influence on vaccination response. Chronic GVHD neither influenced the patient's ability to retain poliovirus antibodies prior to vaccination nor impaired responses to vaccinations. A vaccination schedule consisting of three IPV doses was equally immunogenic when started at 6 or 18 months after allogeneic BMT.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bmt.1700959", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT", 
    "pagination": "663", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6ffade775367142a100f128e0199e213fc8fb1461cbf239cf32647c7bec50ec4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9383230"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1700959"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023503902"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1700959", 
      "https://app.dimensions.ai/details/publication/pub.1023503902"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29191_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/1700959"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700959'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700959'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700959'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700959'


 

This table displays all metadata directly associated to this object as RDF triples.

179 TRIPLES      21 PREDICATES      51 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1700959 schema:about N0be22cf8a5124a8a8ee8463e4b31d319
2 N0fc048030ef74fe6a57329dce981324e
3 N24e3a5703f124bf897d4018ba90b4d07
4 N3aeb483e75c5421e8b6c562b2f332fcb
5 N6d48666c1cbd45fab3db07577b9f0188
6 N7fb964e2d6a6406db47ef5f56d37f193
7 N8b8b4fb9964342e9a9e75842e49cea0b
8 N90eb8de92861457db19f00853591d1c7
9 Nae3f382d899943508b8d25fc555b6e28
10 Nbacd66889c8046839d8749f7cfb6cbb9
11 Nbf1a8a7f826743578282a77a37bc6d9c
12 Nd0606a1e9bf1494989aff91abf22b97d
13 Nf08a6ef6f0fa487dbe35f6a3649c7083
14 Nff0c91b4ecbd418ead0128595752e7ed
15 anzsrc-for:11
16 anzsrc-for:1107
17 schema:author N50429b75749a4399b43a9285f4a4e633
18 schema:citation https://doi.org/10.1016/0002-9343(80)90380-0
19 https://doi.org/10.1056/nejm197504242921706
20 https://doi.org/10.1056/nejm199501193320303
21 https://doi.org/10.1093/clinids/18.4.547
22 https://doi.org/10.1093/clinids/6.supplement_2.s540
23 https://doi.org/10.1093/infdis/159.4.610
24 https://doi.org/10.1093/infdis/162.2.496
25 https://doi.org/10.1111/j.1699-0463.1996.tb00731.x
26 schema:datePublished 1997-10
27 schema:datePublishedReg 1997-10-01
28 schema:description Forty-five adult HLA-matched sibling BMT recipients were randomized to receive inactivated poliovirus vaccine (IPV) at 6, 8 and 14 months (early group, n = 23) or at 18, 20 and 26 months after BMT (late group, n = 22). Ninety-five percent of the early group patients had protective antibody titres of > or = 4 to poliovirus type 1 (PV1), poliovirus type 2 (PV2) and poliovirus type 3 (PV3) by a microneutralization assay prior to the first vaccination, at 6 months after BMT. The corresponding proportion for the late group patients was only 67% at 18 months. The antibody responses 1 month after each of the three IPV doses were similar in the two vaccination groups, except that four-fold responses occurred more frequently after the first dose to PV2 and PV3 in the late group. All patients had a protective antibody titre to all poliovirus serotypes 1 and 22 months after the third vaccine dose, except one patient in the early group who lacked antibodies to PV3 at 22 months. Acute GVHD accelerated the decrease of poliovirus antibody titres prior to vaccination but had no influence on vaccination response. Chronic GVHD neither influenced the patient's ability to retain poliovirus antibodies prior to vaccination nor impaired responses to vaccinations. A vaccination schedule consisting of three IPV doses was equally immunogenic when started at 6 or 18 months after allogeneic BMT.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N10b1f6dd92af49f9be9d5dc727e84c9a
33 N9fd5cea6e32c4071a13142938f377501
34 sg:journal.1096890
35 schema:name Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT
36 schema:pagination 663
37 schema:productId N9e1374b1ef184942a2c32e3eacaf56ae
38 Nacb196f278324da38cb052b38f062e55
39 Nb04e68da5f214c598b642d6e11390c31
40 Ne74792a199bc413d8cf488fa1c34a6cf
41 Nfb451102b76a466eb0531cee1d6d8351
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023503902
43 https://doi.org/10.1038/sj.bmt.1700959
44 schema:sdDatePublished 2019-04-11T11:52
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher Nf5f351fdb2d64683baf53d30f9b304a8
47 schema:url https://www.nature.com/articles/1700959
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N0be22cf8a5124a8a8ee8463e4b31d319 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Poliomyelitis
53 rdf:type schema:DefinedTerm
54 N0fc048030ef74fe6a57329dce981324e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Adult
56 rdf:type schema:DefinedTerm
57 N10b1f6dd92af49f9be9d5dc727e84c9a schema:volumeNumber 20
58 rdf:type schema:PublicationVolume
59 N24e3a5703f124bf897d4018ba90b4d07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Prospective Studies
61 rdf:type schema:DefinedTerm
62 N3aeb483e75c5421e8b6c562b2f332fcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Antibodies, Viral
64 rdf:type schema:DefinedTerm
65 N50429b75749a4399b43a9285f4a4e633 rdf:first sg:person.0676322133.64
66 rdf:rest N85170b58e297426eab175670e9611145
67 N6d48666c1cbd45fab3db07577b9f0188 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Humans
69 rdf:type schema:DefinedTerm
70 N7fb964e2d6a6406db47ef5f56d37f193 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Poliovirus Vaccine, Inactivated
72 rdf:type schema:DefinedTerm
73 N85170b58e297426eab175670e9611145 rdf:first sg:person.01314120305.26
74 rdf:rest Nd21a707bca044a46bb83eaf38ca5013b
75 N8b8b4fb9964342e9a9e75842e49cea0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Male
77 rdf:type schema:DefinedTerm
78 N90eb8de92861457db19f00853591d1c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Bone Marrow Transplantation
80 rdf:type schema:DefinedTerm
81 N9e1374b1ef184942a2c32e3eacaf56ae schema:name pubmed_id
82 schema:value 9383230
83 rdf:type schema:PropertyValue
84 N9fd5cea6e32c4071a13142938f377501 schema:issueNumber 8
85 rdf:type schema:PublicationIssue
86 Nacb196f278324da38cb052b38f062e55 schema:name doi
87 schema:value 10.1038/sj.bmt.1700959
88 rdf:type schema:PropertyValue
89 Nae3f382d899943508b8d25fc555b6e28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Immunization Schedule
91 rdf:type schema:DefinedTerm
92 Nb04e68da5f214c598b642d6e11390c31 schema:name nlm_unique_id
93 schema:value 8702459
94 rdf:type schema:PropertyValue
95 Nbacd66889c8046839d8749f7cfb6cbb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Graft vs Host Disease
97 rdf:type schema:DefinedTerm
98 Nbf1a8a7f826743578282a77a37bc6d9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Vaccines, Inactivated
100 rdf:type schema:DefinedTerm
101 Ncf399bb9067b4c15ad27eac25489f5ef rdf:first sg:person.0741022770.26
102 rdf:rest rdf:nil
103 Nd0606a1e9bf1494989aff91abf22b97d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Middle Aged
105 rdf:type schema:DefinedTerm
106 Nd21a707bca044a46bb83eaf38ca5013b rdf:first sg:person.01370647451.25
107 rdf:rest Ne29ae77608df460fa4447f8e40f9f395
108 Ndf0eb457fc9342fa923336314d5d26a0 rdf:first sg:person.07531174677.79
109 rdf:rest Ncf399bb9067b4c15ad27eac25489f5ef
110 Ne29ae77608df460fa4447f8e40f9f395 rdf:first sg:person.0630657606.65
111 rdf:rest Ndf0eb457fc9342fa923336314d5d26a0
112 Ne74792a199bc413d8cf488fa1c34a6cf schema:name dimensions_id
113 schema:value pub.1023503902
114 rdf:type schema:PropertyValue
115 Nf08a6ef6f0fa487dbe35f6a3649c7083 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Transplantation Conditioning
117 rdf:type schema:DefinedTerm
118 Nf5f351fdb2d64683baf53d30f9b304a8 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Nfb451102b76a466eb0531cee1d6d8351 schema:name readcube_id
121 schema:value 6ffade775367142a100f128e0199e213fc8fb1461cbf239cf32647c7bec50ec4
122 rdf:type schema:PropertyValue
123 Nff0c91b4ecbd418ead0128595752e7ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Female
125 rdf:type schema:DefinedTerm
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
130 schema:name Immunology
131 rdf:type schema:DefinedTerm
132 sg:journal.1096890 schema:issn 0268-3369
133 1476-5365
134 schema:name Bone Marrow Transplantation
135 rdf:type schema:Periodical
136 sg:person.01314120305.26 schema:familyName Stenvik
137 schema:givenName M
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314120305.26
139 rdf:type schema:Person
140 sg:person.01370647451.25 schema:familyName Ruutu
141 schema:givenName T
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370647451.25
143 rdf:type schema:Person
144 sg:person.0630657606.65 schema:familyName Hovi
145 schema:givenName T
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630657606.65
147 rdf:type schema:Person
148 sg:person.0676322133.64 schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
149 schema:familyName Parkkali
150 schema:givenName T
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676322133.64
152 rdf:type schema:Person
153 sg:person.0741022770.26 schema:familyName Ruutu
154 schema:givenName P
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741022770.26
156 rdf:type schema:Person
157 sg:person.07531174677.79 schema:familyName Volin
158 schema:givenName L
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531174677.79
160 rdf:type schema:Person
161 https://doi.org/10.1016/0002-9343(80)90380-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048876793
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1056/nejm197504242921706 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052170577
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1056/nejm199501193320303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006006309
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1093/clinids/18.4.547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059472952
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1093/clinids/6.supplement_2.s540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059475455
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1093/infdis/159.4.610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059701378
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1093/infdis/162.2.496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059702155
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1111/j.1699-0463.1996.tb00731.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042871098
176 rdf:type schema:CreativeWork
177 https://www.grid.ac/institutes/grid.15485.3d schema:alternateName Helsinki University Central Hospital
178 schema:name Department of Medicine, Helsinki University Central Hospital, Finland.
179 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...